Richard Weisman Md Reisterstown, MD - 21136

Richard Weisman Md is categorized under Internal Medicine Practitioners in Reisterstown, MD and active since 2007.

Richard Weisman Md was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Richard Weisman at the company’s single location by writing to 750 Main St, Reisterstown, Maryland MD 21136 or by phoning (410) 526-7800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Richard Weisman Md
Contact Person: Richard Weisman
Address: 750 Main St, Reisterstown, Maryland 21136
Phone Number: (410) 526-7800
Website Address: clinicalassociatesmd.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Richard Weisman Md was started in 2007 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Richard Weisman for inquiries that concern Richard Weisman Md by calling the company number (410) 526-7800, as your correspondence is most welcome. Additionally, the physical location of the single location of Richard Weisman Md can be found at the coordinates 39.451434,-76.819892 as well as the street address 750 Main St in Reisterstown, Maryland 21136.

For its online presence, you may visit Richard Weisman Md’s website at clinicalassociatesmd.com and engage with its social media outlets through on Twitter and on Facebook.